[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]
- PMID: 29936770
- DOI: 10.3760/cma.j.issn.0253-3766.2018.06.008
[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]
Abstract
Objective: To investigate the clinical value of combined detection of serum miR-378 and miR-21 in gastric cancer (GC). Methods: Eighty-seven patients with GC and 78 patients with colorectal cancer(CRC) from National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences were selected, 83 individuals undergoing healthy physical examination were selected as the healthy controls. The levels of serum miR-378 and miR-21 were detected by quantitative real-time PCR (RT-qPCR) (result data were transformed as log2 for analysis). Results: Relative expression levels of miR-378 in the serum were -1.24, -3.25 and -2.73 in healthy controls, GC and CRC patients, respectively. Compared with the healthy controls, the levels of serum miR-378 were significantly decreased in GC and CRC patients (both P<0.05). Relative expression levels of miR-21 in the serum were 0.11, 2.34 and 2.47 in healthy controls, GC and CRC patients, respectively. Compared with the healthy controls, the levels of serum miR-21 were significantly up-regulated in GC and CRC patients (both P<0.05). Moreover, the serum level of miR-378 in GC patients was inversely associated with tumor clinical stage (P<0.05). However, the level of miR-21 showed no significant differences among patients with different clinical and pathological characteristics (all P>0.05). The area under the receiver operating characteristic curve (AUC), sensitivity and specificity of miRNA-378 to diagnose GC was 0.770, 82.0% and 66.0%, respectively, and were 0.900, 85.0%, and 88.0% of miR-21, respectively. The AUC, sensitivity and specificity of combined detection of serum miR-378 and miR-21 to diagnose GC were 0.930, 92.0% and 87.0%, respectively, while the AUC of combined detection of serum CEA and CA-199 was 0.767, the AUC of combined all of the four factors was 0.946. Conclusion: The combined detection of serum miR-378 and miR-21 have a certain effect on diagnosis of GC.
目的: 探讨血清miR-378和miR-21联合检测对胃癌的临床诊断价值。 方法: 选择中国医学科学院肿瘤医院经病理确诊的胃癌患者87例,结直肠癌患者78例,健康体检者83例,采用实时荧光定量PCR法检测血清样本中miR-378和miR-21的表达水平(以log(2)对结果进行转换)。 结果: miR-378在健康对照者、胃癌患者和结直肠癌患者血清中的相对表达水平分别为-1.24、-3.25和-2.73,miR-378在胃癌和结直肠癌患者血清中的相对表达水平明显低于健康对照者(均P<0.05)。miR-21在健康对照者、胃癌患者和结直肠癌患者血清中的相对表达水平分别为0.11、2.34和2.47,miR-21在胃癌和结直肠癌患者血清中的相对表达水平明显高于健康对照者(均P<0.05)。胃癌患者血清中miR-378的低表达与肿瘤的临床分期有关(P<0.05),分期越晚,下降程度越大;而miR-21在胃癌患者血清中的升高程度与患者的临床病理特征无关(均P>0.05)。血清miR-378诊断胃癌的曲线下面积(AUC)为0.770,灵敏度为82.0%,特异度为66.0%;miR-21诊断胃癌的AUC为0.900,灵敏度为85.0%,特异度为88.0%;miR-378+miR-21诊断胃癌的AUC为0.930,灵敏度为92.0%,特异度为87.0%。CEA+CA-199诊断胃癌的AUC为0.767,CEA+CA-199+miR-378+miR-21诊断胃癌的AUC为0.946。 结论: 联合检测血清中miR-378和miR-21的表达对胃癌具有一定的诊断效能。.
Keywords: Diagnose; Gastric neoplasms; Serum; miR-21; miR-378.
Similar articles
-
Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.Iran Biomed J. 2017 Mar;21(2):106-13. doi: 10.18869/acadpub.ibj.21.2.106. Epub 2016 Jul 19. Iran Biomed J. 2017. PMID: 27432735 Free PMC article.
-
Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.J Dig Dis. 2018 Jul;19(7):404-410. doi: 10.1111/1751-2980.12643. J Dig Dis. 2018. PMID: 29952077
-
Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.PLoS One. 2012;7(7):e41629. doi: 10.1371/journal.pone.0041629. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860003 Free PMC article.
-
The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review.Oncotarget. 2017 Jul 11;8(28):45060-45071. doi: 10.18632/oncotarget.15023. Oncotarget. 2017. PMID: 28178677 Free PMC article. Review.
-
Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.Genet Mol Res. 2015 Dec 22;14(4):18018-25. doi: 10.4238/2015.December.22.28. Genet Mol Res. 2015. PMID: 26782449
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous